Clinical Trial Detail

NCT ID NCT00971737
Title Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Trastuzumab

Cyclophosphamide

Age Groups: adult

Additional content available in CKB BOOST